What Really Mattered With Novavax's Q4 Update

Keith Speights, The Motley Fool
·3-min read
What Really Mattered With Novavax's Q4 Update

Novavax (NASDAQ: NVAX) just provided a great example of this. Novavax reported Q4 revenue of $279.7 million. On the other hand, Novavax's bottom line in the fourth quarter was the worst it's ever been.